142 related articles for article (PubMed ID: 11550304)
1. Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading.
Levin VA
Neuro Oncol; 1999 Jan; 1(1):69-80. PubMed ID: 11550304
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment of glyal and metastatic tumors of the brain].
Fadeev BP; Zhabina RM
Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
[TBL] [Abstract][Full Text] [Related]
3. Low-grade oligodendroglioma: current treatments and future hopes.
Lwin Z; Gan HK; Mason WP
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1651-61. PubMed ID: 19895248
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors.
Wakabayashi T; Kajita Y; Mizuno M; Nagasaka T; Yoshida J
Neurol Med Chir (Tokyo); 2001 Mar; 41(3):115-9; discussion 119-20. PubMed ID: 11372553
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage.
Hofer S; Herrmann R
J Cancer Res Clin Oncol; 2001 Feb; 127(2):91-5. PubMed ID: 11216919
[TBL] [Abstract][Full Text] [Related]
6. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230
[TBL] [Abstract][Full Text] [Related]
7. [Gliomas in adults: primary non-surgical treatment].
Poulsen HS
Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic factors in chemotherapy of recurrent brain tumors.
Eagan RT; Scott M
J Clin Oncol; 1983 Jan; 1(1):38-44. PubMed ID: 6321671
[TBL] [Abstract][Full Text] [Related]
9. [Glioma therapy up-date].
de la Fuente BP; Dalmau J; Rosenfeld M
Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
[TBL] [Abstract][Full Text] [Related]
10. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M
Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of chemotherapy for malignant brain tumors].
Takeshima H; Kuratsu J
No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
[No Abstract] [Full Text] [Related]
12. Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors.
Wakabayashi T; Kajita Y; Hatano N; Thompson T; Nagasaka T; Yoshida J
Brain Tumor Pathol; 2000; 17(1):29-33. PubMed ID: 10982007
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of primary malignant brain tumors in adults].
Hoang-Xuan K; Delattre JY
Rev Prat; 1996 Feb; 46(4):450-6. PubMed ID: 8729351
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant temozolomide: how long and how much?
Franceschi E; Tosoni A; Brandes AA
Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
[No Abstract] [Full Text] [Related]
15. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Siker ML; Chakravarti A; Mehta MP
Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
17. [New place of the chemotherapy in gliomas].
Chinot O
Bull Cancer; 2005 Apr; 92(4):343-54. PubMed ID: 15888391
[TBL] [Abstract][Full Text] [Related]
18. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Afra D; Sipos L; Vitanovics D
Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
Khasraw M; Bell D; Wheeler H
J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
